(2011) reported that changed 2-AG signaling throughout late phases of AD because of the combination of impaired recruitment of monoacylglycerol lipase (MAGL) as well as raised levels of diacylglycerol lipase that promote synapse silencing in AD. Here, MGLL is linked to Alzheimer disease.